Tom is a healthcare innovator, strategist and change agent. He served Pfizer in a number of senior roles
including head of strategy for Pfizer’s Biotherapeutics and Bioinnovation Center. There, he initiated innovative
efforts spanning business strategy, operational change and clinical development programs.
Prior to Pfizer, Tom held a number of senior strategic advisory positions at Aperion Partners, MTM Advisors,
Wood Mackenzie and PA Consulting Group.
Tom is cofounder of BioLogic Technologies, Miragen and most recently Naia Pharmaceuticals. He also
cofounded MIT’s NEW Drug Development ParaDIGmS (NEWDIGS) program and still serves on its Executive